DAX24.194 +0,1%ESt505.383 +0,2%Top 10 Crypto15,24 -4,9%Dow44.460 +0,2%Nas20.640 +0,3%Bitcoin100.208 -2,4%Euro1,1683 +0,1%Öl68,98 -0,2%Gold3.360 +0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA NVIDIA 918422 RENK RENK73 Clara Technologies A3E4MS Volatus Aerospace A2JEQU HENSOLDT HAG000 Tesla A1CX3T BASF BASF11 Lufthansa 823212 Siemens Energy ENER6Y Commerzbank CBK100 Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 thyssenkrupp 750000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX steigt -- EU bereitet Liste für Vergeltungszölle vor -- NVIDIA darf Chips nach China verkaufen -- Robinhood verpasst S&P 500-Einzug -- Red Cat, Palantir, BYD, DroneShield im Fokus
Top News
Aktien von Rheinmetall, RENK und HENSOLDT atmen durch: Rheinmetall präsentiert Drohnen-Schutzsystem Aktien von Rheinmetall, RENK und HENSOLDT atmen durch: Rheinmetall präsentiert Drohnen-Schutzsystem
Tesla-Aktie im Krisenmodus: Politische Eskapaden, sinkende Verkäufe - nächste Bewährungsprobe steht bevor Tesla-Aktie im Krisenmodus: Politische Eskapaden, sinkende Verkäufe - nächste Bewährungsprobe steht bevor
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Neue Bitcoin-Rally gestartet? Jetzt bei Plus500 handeln und von Kursbewegungen profitieren!

EQS-Adhoc: thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment

15.07.25 09:13 Uhr
Werte in diesem Artikel
Aktien
thyssenkrupp nucera AG & Co. KGaA
10,18 EUR -0,03 EUR -0,29%
Charts|News|Analysen
Aktie kaufen

EQS-Ad-hoc: thyssenkrupp nucera AG & Co. KGaA / Key word(s): Change in Forecast/Preliminary Results
thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment

15-Jul-2025 / 09:13 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung

thyssenkrupp nucera specifies outlook for fiscal year 2024/25 based on preliminary Q3/9M 2024/25 business development and slightly raises EBIT expectation for the Group and the Chlor-Alkali segment
  • thyssenkrupp nucera AG & Co. KGaA ("thyssenkrupp nucera"), based on the preliminary business development of the first nine months of 2024/25, specifies and partially raises the outlook for the most important financial performance indicators sales and EBIT for fiscal year 2024/25 published in the combined management report 2023/24 and confirmed in the half-year financial report 2024/25.
Outlook for the 2024/25 financial year
  • At Group level, thyssenkrupp nucera now expects sales of between EUR 850 million and EUR 920 million (2023/24: EUR 862 million) and is raising the EBIT range to between EUR -7 million and EUR 7 million (2023/24: EUR -14 million). Previously, thyssenkrupp nucera had assumed sales of between EUR 850 million and EUR 950 million and EBIT of between EUR -30 million and EUR 5 million for the 2024/25 financial year.
  • In the gH2 segment, sales of between EUR 450 million and EUR 510 million (2023/24: EUR 524 million) are now expected, with EBIT of between EUR -75 million and EUR -55 million (2023/24: EUR -76 million). thyssenkrupp nucera had previously expected sales of between EUR 450 million and EUR 550 million and an improvement in EBIT to a negative mid-double-digit million euro amount.
  • In the CA segment, sales expectation continue to range from EUR 380 million to EUR 420 million (2023/24: EUR 338 million). The EBIT outlook has been raised. EBIT in the CA segment is now expected to be between EUR 55 million and EUR 75 million (2023/24: EUR 62 million). Previously, thyssenkrupp nucera had assumed a positive EBIT in the mid double-digit million euro range below the previous year's figure in the CA segment.
Preliminary business development Q3/9M 2024/25
  • Based on preliminary, unaudited figures, thyssenkrupp nucera expects sales of EUR 184 million for the third quarter of 2024/25 (Q3 2023/24: EUR 237 million). This puts Group sales below the level of the previous quarter. Sales of EUR 103 million (Q3 2023/24: EUR 134 million) are expected in the Green Hydrogen (gH2) segment and sales of EUR 81 million (Q3 2023/24: EUR 103 million) in the Chlor-Alkali (CA) segment.
  • Furthermore, thyssenkrupp nucera expects earnings before interest and taxes (EBIT) of EUR 0 million for the third quarter of 2024/25 (Q3 2023/24: EUR 2 million). EBIT in the gH2 segment rose to EUR -13 million (Q3 2023/24: EUR -23 million). EBIT in the CA segment amounted to EUR 13 million (Q3 2023/24: EUR 25 million). In the same quarter of the previous year, EBIT in the CA segment benefited from positive one-off effects.
  • This results in sales of EUR 663 million in the first nine months of 2024/25 (9M 2023/24: EUR 609 million), of which EUR 377 million is attributable to the gH2 segment (9M 2023/24: EUR 350 million) and EUR 286 million to the CA segment (9M 2023/24: EUR 259 million). Cumulative EBIT improved to EUR 4 million in the first nine months of 2024/25 (9M 2023/24: EUR -13 million). EBIT in the gH2 segment amounted to EUR -39 million (9M 2023/24: EUR -61 million) and in the CA segment to EUR 43 million (9M 2023/24: EUR 47 million).
  • Incoming orders amounted to EUR 63 million in the third quarter of 2024/25 (Q3 2023/24: EUR 271 million). Of this, EUR 13 million were attributable to the gH2 segment (Q3 2023/24: EUR 220 million) and EUR 50 million to the CA segment (Q3 2023/24: EUR 51 million). In the same period of the previous year, around EUR 200 million were recognized in incoming orders in connection with the Stegra project. The total order backlog at Group level amounted to around EUR 0.7 billion as of June 30, 2025.
All published figures and statements are preliminary and unaudited. The detailed Q3/9M 2024/25 results will be published on August 13, 2025 at 07:00 CEST.

Key financial figures: Explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/2024 Annual Report on pages 53 to 54, available at the following link: https://investors.thyssenkrupp-nucera.com/investors/publications


End of Inside Information

15-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2169678

 
End of Announcement EQS News Service
Wer­bung

2169678  15-Jul-2025 CET/CEST

Ausgewählte Hebelprodukte auf thyssenkrupp nucera

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf thyssenkrupp nucera

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu thyssenkrupp nucera AG & Co. KGaA

DatumMeistgelesen
Wer­bung

Analysen zu thyssenkrupp nucera AG & Co. KGaA

DatumRatingAnalyst
23.06.2025thyssenkrupp nucera BuyDeutsche Bank AG
20.06.2025thyssenkrupp nucera OutperformRBC Capital Markets
04.06.2025thyssenkrupp nucera OutperformRBC Capital Markets
04.06.2025thyssenkrupp nucera BuyDeutsche Bank AG
16.05.2025thyssenkrupp nucera BuyDeutsche Bank AG
DatumRatingAnalyst
23.06.2025thyssenkrupp nucera BuyDeutsche Bank AG
20.06.2025thyssenkrupp nucera OutperformRBC Capital Markets
04.06.2025thyssenkrupp nucera OutperformRBC Capital Markets
04.06.2025thyssenkrupp nucera BuyDeutsche Bank AG
16.05.2025thyssenkrupp nucera BuyDeutsche Bank AG
DatumRatingAnalyst
20.12.2024thyssenkrupp nucera HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.12.2024thyssenkrupp nucera NeutralGoldman Sachs Group Inc.
17.12.2024thyssenkrupp nucera NeutralGoldman Sachs Group Inc.
19.11.2024thyssenkrupp nucera NeutralGoldman Sachs Group Inc.
16.08.2024thyssenkrupp nucera HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
30.01.2025thyssenkrupp nucera SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für thyssenkrupp nucera AG & Co. KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen